Source:http://linkedlifedata.com/resource/pubmed/id/11423935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2001-6-25
|
pubmed:abstractText |
Antisense oligodeoxynucleotides (ODNs) appear as attractive anti-hepatitis B virus (HBV) agents. We investigated in vivo, in the duck HBV (DHBV) infection model, whether linear polyethylenimine (lPEI)-based intravenous delivery of the natural antisense phosphodiester ODNs (O-ODNs) can prevent their degradation and allow viral replication inhibition in the liver. DHBV-infected Pekin ducklings were injected with antisense O-ODNs covering the initiation codon of the DHBV large envelope protein, either in free form (O-ODN-AS2) or coupled to lPEI (lPEI/O-ODN-AS2). Following optimization of lPEI/O-ODN complex formulation, complete O-ODN condensation into a homogenous population of small (20-60 nm) spherical particles was achieved. Flow cytometry analysis showed that lPEI-mediated transfer allowed the intrahepatic delivery of lPEI/O-ODN-AS2 to increase three-fold as compared with the O-ODN-AS2. Following 9-day therapy the intrahepatic levels of both DHBV DNA and RNA were significantly decreased in the lPEI/O-ODN-AS2-treated group as compared with the O-ODN-AS2-treated, control lPEI/O-ODN-treated, and untreated controls. In addition, inhibition of intrahepatic viral replication by lPEI/O-ODN-AS2 was not associated with toxicity and was comparable with that induced by the phosphorothioate S-ODN-AS2 at a five-fold higher dose. Taken together, our results demonstrate that phosphodiester antisense lPEI/O-ODN complexes specifically inhibit hepadnaviral replication. Therefore we provide here the first in vivo evidence that intravenous treatment with antisense phosphodiester ODNs coupled to lPEI can selectively block a viral disease-causing gene in the liver.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0969-7128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
874-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11423935-Animals,
pubmed-meshheading:11423935-Gene Therapy,
pubmed-meshheading:11423935-Hepadnaviridae Infections,
pubmed-meshheading:11423935-Hepatitis B Virus, Duck,
pubmed-meshheading:11423935-Immunoblotting,
pubmed-meshheading:11423935-Kidney,
pubmed-meshheading:11423935-Liver,
pubmed-meshheading:11423935-Lung,
pubmed-meshheading:11423935-Microscopy, Confocal,
pubmed-meshheading:11423935-Microscopy, Fluorescence,
pubmed-meshheading:11423935-Models, Animal,
pubmed-meshheading:11423935-Oligonucleotides, Antisense,
pubmed-meshheading:11423935-Polyethyleneimine,
pubmed-meshheading:11423935-Spleen,
pubmed-meshheading:11423935-Virus Replication
|
pubmed:year |
2001
|
pubmed:articleTitle |
Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
|
pubmed:affiliation |
INSERM U271, Lyon, France, and Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdansk, Poland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|